ALT5 Sigma Corporation (ALTS)

In December 2025, a shareholder rights law firm initiated an investigation into ALT5 Sigma due to potential governance issues and regulatory non-compliance, leading to a stock decline. This followed revelations about a subsidiary's criminal liability in Rwanda and leadership turmoil. In January 2026, ALT5 Sigma announced a stock buyback program and launched ALT5 AI, causing a stock price surge. In February 2026, the company updated on efforts to restore compliance. By March 30, 2026, the stock price was $1.12, reflecting significant declines over the past year, month, and six months.

Specific information on demand seasonality for ALT5 Sigma's products and services is not readily available. The available data primarily discusses the seasonality of the ALTS stock price, indicating that August has historically shown the highest probability of positive returns, while March may not be an ideal month for investment. However, this does not directly reflect seasonal demand for the company's offerings.

ALT5 Sigma Corporation is a technology company operating globally through Fintech and Biotechnology segments. It specializes in blockchain-powered technologies, offering infrastructure for digital asset tokenization, trading, and secure safekeeping. Key fintech products include ALT5 Prime and ALT5 Pay. The Biotechnology segment focuses on developing non-opioid therapies for pain and addiction, with product candidates like JAN 101 and JAN123. Formerly known as JanOne Inc., the company rebranded in July 2024 and is categorized within the Technology sector.

Headquartered in Las Vegas, Nevada, ALT5 Sigma provides blockchain-powered technologies worldwide, serving financial institutions, fintechs, payment providers, and merchants globally. Its stock is listed on several European exchanges, including Frankfurt, Stuttgart, Munich, and Dusseldorf.

ALT5 Sigma's brand reputation has been negatively impacted by a shareholder rights law firm investigation, citing regulatory and management failures, and a subsidiary's criminal conviction for money laundering. This led to a stock price drop and concerns about internal controls. Despite these challenges, there have been some indications of improving investor sentiment, with the stock rising 19% in April 2026 and a news sentiment score of 1.45 as of March 31, 2026.

ALT5 Sigma Corporation's ownership is a mix of institutional, retail, and individual investors. Approximately 33.23% of the stock is owned by institutional investors, 0.05% by insiders, and 66.72% by public companies and individual investors. Major institutional shareholders include CRCM L.P., Diametric Capital, LP, The Vanguard Group, Inc., Prelude Capital Management, Llc, BlackRock, Inc., Jane Street Group, Llc, UBS Group AG, Citadel Advisors Llc, Geode Capital Management, Llc and Jump Financial, LLC.